Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Droxidopa MeSH Descriptor Data 2026


MeSH Heading
Droxidopa
Tree Number(s)
D02.092.311.830.220
D02.455.426.559.389.657.166.175.830.220
D12.125.154.800.875
Unique ID
D015103
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015103
Scope Note
A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.
Entry Term(s)
3,4-Dihydroxyphenylserine
3,4-threo-DOPS
DL-threo-3,4-Dihydroxyphenylserine
Droxidopa, (DL-Tyr)-Isomer
erythro-3,4-Dihydroxyphenylserine
threo-DOPS
Pharm Action
Antiparkinson Agents
Registry Numbers
J7A92W69L7
0
13147-26-7
Related Numbers
13147-26-7
23651-95-8
CAS Type 1 Name
L-Tyrosine, beta,3-dihydroxy-, threo-
Previous Indexing
Catechols (1971-1974)
Serine (1971-1974)
Public MeSH Note
1997; see 3,4-DIHYDROXYPHENYLSERINE 1975-96
History Note
1997 (1975); use 3,4-DIHYDROXYPHENYLSERINE 1975-1996
Date Introduced
1991/01/01
Last Updated
2018/05/29
Droxidopa Preferred
3,4-Dihydroxyphenylserine Broader
erythro-3,4-Dihydroxyphenylserine Related
Droxidopa, (DL-Tyr)-Isomer Related
page delivered in 0.13s